The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail


100 milligram(s) Pdr+Solv for conc/solv for inf

Menarini International Operations Luxembourg S.A.EU/1/15/1055/001

Main Information

Trade NameCiambra
Active SubstancesPemetrexed disodium
Strength100 milligram(s)
Dosage FormPdr+Solv for conc/solv for inf
Licence HolderMenarini International Operations Luxembourg S.A.
Licence NumberEU/1/15/1055/001

Group Information

ATC CodeL01BA Folic acid analogues
L01BA04 pemetrexed


Licence Issued02/12/2015
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back